{"id":13308,"date":"2011-06-09T00:00:00","date_gmt":"2011-06-09T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/congressvpharma\/"},"modified":"2019-03-01T12:12:30","modified_gmt":"2019-03-01T12:12:30","slug":"congressvpharma","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/","title":{"rendered":"110th Congress: What&#8217;s in Store for Pharma?"},"content":{"rendered":"<p>   <a name=\"top\"\/> <b>110th Congress: What&#8217;s in Store for Pharma?<\/b><br \/> <b><a href=\"#results\">Click here to see the results of this survey<\/a>.<\/b>   <\/p>\n<p> Survey began 20 November 2006<br \/>   Survey ended 31 December 2006<\/p>\n<p>   <br clear=\"all\"\/> <b>Background<\/b><br \/>   Now that the elections are over, the pharmaceutical industry is left to ponder what the new Congress has in store for it. There has already been a lot of speculation in the general press and trade media as well as a few shots fired across the bow by Congress.   <\/p>\n<p> It&#8217;s not just democrats itching to get at Pharma. For example, the Senate Committee on Health, Education, Labor, and Pensions (HELP) chaired by Sen. Michael B. Enzi (R-Wyoming), met in full session on November 16, 2006 (&#8220;Hearing on Building a 21st Century FDA: Proposals to Improve Drug Safety and Innovation;&#8221; access audio and testimony from this hearing here) and Senator Charles Grassley (R-Iowa) has put a hold on the nomination of Dr. Andrew C. von Eschenbach for commissioner of the FDA.   <\/p>\n<p> The following is a synopsis of the issues and changes experts have predicted that the drug industry will be subjected to in the next legislative session:   <\/p>\n<p> <b>Drug Price Related<\/b>   <\/p>\n<ul type=\"DISC\">\n<li>Medicare reform &#8212; allow government to directly negotiate prices with pharmaceutical companies     <\/li>\n<li>Allow drug importation from Canada     <\/li>\n<li>Patent Reform &#8212; set limits on whether big pharmaceutical firms can make deals with generic drug makers   <\/li>\n<\/ul>\n<p> <b>Marketing Related<\/b>   <\/p>\n<ul type=\"DISC\">\n<li>Enact a mandatory 6-month, one- or two-year moratorium on ads for new drugs     <\/li>\n<li>Require FDA pre-clearance of all DTC ads     <\/li>\n<li>Wipe out or limiting tax deductions for advertising expense     <\/li>\n<li>Require a &#8220;black triangle&#8221; in ads and labels for new drugs     <\/li>\n<li>Set standards for risk presentation that make broadcast ads infeasible   <\/li>\n<\/ul>\n<p> <b>FDA\/Drug Approval\/Safety Related<\/b>   <\/p>\n<ul type=\"DISC\">\n<li>Hold up of Prescription Drug User Fee Act (PDUFA) reauthorization     <\/li>\n<li>Make FDA more powerful &#8212; eg, create office of drug safety within FDA, give the FDA the power to fine companies to force them to do safety studies or change the labels of drugs (Grassley-Dodd and Enzi-Kennedy bills)   <\/li>\n<\/ul>\n<p> <b>The survey asks<\/b>: Regardless of how you feel personally about whether or not such legislation should be passed, please indicate how likely or unlikely you believe Congress will enact the above.   <\/p>\n<\/p>\n<p> <a name=\"results\"\/> <b>Survey Results:<\/b> <\/p>\n<ul>\n<li><b><a href=\"http:\/\/www.surveymonkey.com\/Report.asp?U=291261388846\" target=\"_blank\">Interactive Summary of Results<\/a><\/b> (de-identified, excludes open-ended responses and comments that may      identify the respondent). Allows you to use filters to examine results      from different subsets of respondents (e.g., pharma company employees      vs. non-pharma people, etc.)<\/li>\n<li><b><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn510-article01.html\">Congress vs. Pharma: Trouble Ahead?<\/a><\/b> This article is a summary of a <a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/pmroundtable\/pmrt112806.htm\">Pharma Marketing Roundtable discussion<\/a> of the Congressional agenda for pharma (real and feared). Includes results from the online &#8220;What&#8217;s In Store From Congress&#8221; survey. <\/li>\n<\/ul>\n<p> <i><a href=\"http:\/\/www.surveys.pharma-mkting.com\/surveys-hp.htm\">Return to list of surveys&#8230;<\/a><\/i> <\/p>\n","protected":false},"excerpt":{"rendered":"<p>110th Congress: What&#8217;s in Store for Pharma? Click here to see the results of this survey. Survey began 20 November 2006 Survey ended 31 December 2006 Background Now that the elections are over, the pharmaceutical industry is left to ponder what the new Congress has in store for it. There has already been a lot [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":13101,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1204],"tags":[],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>110th Congress: What&#039;s in Store for Pharma? - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"110th Congress: What&#039;s in Store for Pharma? - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"110th Congress: What&#8217;s in Store for Pharma? Click here to see the results of this survey. Survey began 20 November 2006 Survey ended 31 December 2006 Background Now that the elections are over, the pharmaceutical industry is left to ponder what the new Congress has in store for it. There has already been a lot [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2011-06-09T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-03-01T12:12:30+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/pmn-logo-intro-post-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"744\" \/>\n\t<meta property=\"og:image:height\" content=\"419\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/\",\"name\":\"110th Congress: What's in Store for Pharma? - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2011-06-09T00:00:00+00:00\",\"dateModified\":\"2019-03-01T12:12:30+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"110th Congress: What&#8217;s in Store for Pharma?\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"110th Congress: What's in Store for Pharma? - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/","og_locale":"en_US","og_type":"article","og_title":"110th Congress: What's in Store for Pharma? - Pharma Marketing Network","og_description":"110th Congress: What&#8217;s in Store for Pharma? Click here to see the results of this survey. Survey began 20 November 2006 Survey ended 31 December 2006 Background Now that the elections are over, the pharmaceutical industry is left to ponder what the new Congress has in store for it. There has already been a lot [&hellip;]","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/","og_site_name":"Pharma Marketing Network","article_published_time":"2011-06-09T00:00:00+00:00","article_modified_time":"2019-03-01T12:12:30+00:00","og_image":[{"width":744,"height":419,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/pmn-logo-intro-post-1.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/","name":"110th Congress: What's in Store for Pharma? - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2011-06-09T00:00:00+00:00","dateModified":"2019-03-01T12:12:30+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/congressvpharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"110th Congress: What&#8217;s in Store for Pharma?"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/13308"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=13308"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/13308\/revisions"}],"predecessor-version":[{"id":13391,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/13308\/revisions\/13391"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/13101"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=13308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=13308"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=13308"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=13308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}